Tekmira: This Could Take a While
October 01, 2014 at 09:58 AM EDT
The stocks of biotech companies working on Ebola treatments, including Tekmira Pharmaceuticals (TKMR), Hemispherx BioPharma (HEB), NewLink Genetics (NLNK) and BioCryst Pharmaceuticals (BCRX), are flying today after the first case of the disease in the U.S. was confirmed. Agence France-Presse/Getty Images Investors might not want to get overconfident, at least when it comes to Tekmira. That’s because [...]